Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Stock picking may pay off in certain market conditions and for investors with time and expertise. Learn factors to consider before deviating from index funds.
26,454 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Capricor's small-cap biotech story hinges on milestones, cash runway, and clinical progress. This guide breaks down w...
A new income-focused ETF blend aims to provide steady monthly cash flow even as markets swing. By splitting $100,000 ...
A wave of institutional interest is reshaping AI infrastructure stocks. This guide explains why capital is flowing in...
The market has rallied, but high valuations ring warning bells. This guide explains what the stock market sounds alar...
Vertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
Stocks wobbled as a memory-chip selloff led by South Korea dragged down Micron and peers. This article breaks down wh...
spacex tokenized stock bets surged as crypto leverage spilled into equities, with more than $50 million in 48-hour li...
Investors are eyeing a nuclear energy stock with outsized upside as regulatory momentum and a growing project pipelin...
Geopolitical headlines push risk-off moves while Hut 8 leads a tech rally on AI data center news. This guide breaks d...
A high-stakes move by a leading investment manager has turned heads in the tech infrastructure space. This article ex...
A CFO's share sale coincides with bold guidance and a explosive stock rally. This look at what this butterfly network...